Sanofi to buy immunology biotech Blueprint for US$9.1 billion
Sanofi agreed to buy Blueprint Medicines for at least US$9.1 billion as the French drugmaker expands further in rare immunological ...
Sanofi agreed to buy Blueprint Medicines for at least US$9.1 billion as the French drugmaker expands further in rare immunological ...
France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in ...
Breadcrumb Trail LinksLongreadsNewsWorldNayib Bukele of El Salvador, Javier Milei of Argentina, and Daniel Noboa of Ecuador, have formed a new ...
Tech entrepreneur Bryan Johnson, dubbed the "anti-ageing millionaire", has been accused of using nondisclosure agreements to silence employees at his ...
Ellie Simmonds was one of the faces of the London 2012 Paralympics, winning two gold medals, four years after she ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.